awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42344607-4E6D7F41-30D9-4252-8411-7E50F6891ECF
Q42344607-4E6D7F41-30D9-4252-8411-7E50F6891ECF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42344607-4E6D7F41-30D9-4252-8411-7E50F6891ECF
New immunotherapeutic paradigms for castration-resistant prostate cancer.
P2860
Q42344607-4E6D7F41-30D9-4252-8411-7E50F6891ECF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42344607-4E6D7F41-30D9-4252-8411-7E50F6891ECF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c54d9de8004664c30a1bc563529f8445caa3b469
P2860
NICE guidance on cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.